First Trust launches nuclear power ETF tracking Bloomberg index

First Trust Advisors L.P. launched the First Trust Bloomberg Nuclear Power ETF (NYSE Arca: RCTR), which seeks to track the Bloomberg Nuclear Power Index. The fund provides exposure to companies involved in nuclear-related activities across uranium, power generation, and equipment and engineering services.

The Bloomberg Nuclear Power Index includes up to 50 companies selected based on their revenue exposure to nuclear power and market capitalization. Eligible companies are evaluated on expected revenue exposure to the nuclear power ecosystem, along with operational and financial characteristics including production scalability, capital allocation trends, customer relationships, and access to capital.

"Increasing demand for clean and reliable energy to power artificial intelligence, electric vehicles, and industrial reshoring is fueling renewed interest in nuclear power," said Ryan Issakainen, Senior Vice President and ETF Strategist at First Trust. "RCTR offers investors a targeted strategy that seeks to provide exposure to the growing nuclear power ecosystem."

Allison Stone, Head of Multi-Asset Index Product Management at Bloomberg Index Services Limited, said the index "was developed to provide a transparent, rules-based view into the global nuclear energy value chain."

First Trust manages approximately $278 billion in assets as of June 30, 2025, through various investment vehicles including unit investment trusts, exchange-traded funds, closed-end funds, mutual funds and separate managed accounts.

The fund faces risks including nuclear power companies' exposure to accidents, security breaches, terrorism, natural disasters, and regulatory changes. Nuclear operations are subject to strict safety, environmental, and security standards that may become more stringent, potentially increasing costs.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• Nippon Paint Said To Offer $8.6 Billion For Akzo's Paint Arm - Bloomberg
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight